Skip to main content Accessibility help
×
Home
  • Print publication year: 2014
  • Online publication date: May 2014

Chapter 41 - Stemcell therapies for brain disorders

from Section 7 - Translational research: application to human neural injury

References

1. MancardiG, SaccardiR. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol 2008; 7: 626–36.
2. SaccardiR, KozakT, Bocelli-TyndallC, et al. Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler 2006; 12: 814–23.
3. ShevchenkoYL, NovikAA, KuznetsovAN, et al. High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis. Exp Hematol 2008; 36: 922–8.
4. AtkinsH, FreedmanM. Immune ablation followed by autologous hematopoietic stem cell transplantation for the treatment of poor prognosis multiple sclerosis. Methods Mol Biol 2009; 549: 231–46.
5. RogojanC, FrederiksenJL. Hematopoietic stem cell transplantation in multiple sclerosis. Acta Neurol Scand 2009; 120: 371–82.
6. SospedraM, MartinR. Immunology of multiple sclerosis. Annu Rev Immunol 2005; 23: 683–747.
7. KarussisD, GrigoriadisS, PolyzoidouE, et al. Neuroprotection in multiple sclerosis. Clin Neurol Neurosurg 2006; 108: 250–4.
8. SteinmanL. Multiple sclerosis: a two-stage disease. Nat Immunol 2001; 2: 762–4.
9. KornT, BettelliE, OukkaM, et al. IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27: 485–517.
10. TrappBD, PetersonJ, RansohoffRM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278–85.
11. SiatskasC, BernardCC. Stem cell and gene therapeutic strategies for the treatment of multiple sclerosis. Curr Mol Med 2009; 9: 992–1016.
12. FranklinRJ. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 2002; 3: 705–14.
13. SlavinS. Successful treatment of autoimmune disease in (NZB/NZW)F1 female mice by using fractionated total lymphoid irradiation. Proc Natl Acad Sci U S A 1979; 76: 5274–6.
14. LoewenthalE, WeissL, SamuelS, et al. Optimization of conditioning therapy for leukemia prior to BMT. I. Optimal synergism between cyclophosphamide and total body irradiation for eradication of murine B cell leukemia (BCL1). Bone Marrow Transplant 1993; 12: 109–13.
15. KarussisDM, SlavinS, Ben-NunA, et al. Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation. J Neuroimmunol 1992; 39: 201–10.
16. ReynoldsBA, WeissS. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 1996; 175: 1–13.
17. DanielyanL, SchaferR, von Ameln-MayerhoferA, et al. Intranasal delivery of cells to the brain. Eur J Cell Biol 2009; 88: 315–24.
18. CriglerL, RobeyRC, AsawachaicharnA, et al. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 2006; 198: 54–64.
19. MunozJR, StoutengerBR, RobinsonAP, et al. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci U S A 2005; 102: 18171–6.
20. KassisI, GrigoriadisN, Gowda-KurkalliB, et al. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 2008; 65: 753–61.
21. ReynoldsBA, WeissS. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992; 255: 1707–10.
22. ParkerMA, AndersonJK, CorlissDA, et al. Expression profile of an operationally-defined neural stem cell clone. Exp Neurol 2005; 194: 320–32.
23. SvendsenCN, CaldwellMA, ShenJ, et al. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson’s disease. Exp Neurol 1997; 148: 135–46.
24. GageFH. Mammalian neural stem cells. Science 2000; 287: 1433–8.
25. WeissS, DunneC, HewsonJ, et al. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci 1996; 16: 7599–609.
26. PalmerTD, MarkakisEA, WillhoiteAR, et al. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J Neurosci 1999; 19: 8487–97.
27. Ben-HurT. Cell therapy for multiple sclerosis. Neurotherapeutics 2011; 8: 625–42.
28. EinsteinO, FainsteinN, VakninI, et al. Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression. Ann Neurol 2007; 61: 209–18.
29. GerdoniE, GalloB, CasazzaS, et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 2007; 61: 219–27.
30. PluchinoS, QuattriniA, BrambillaE, et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003; 422: 688–94.
31. da Silva MeirellesL, ChagastellesPC, NardiNB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119: 2204–13.
32. CaplanAI. All MSCs are pericytes? Cell Stem Cell 2008; 3: 229–30.
33. PittengerMF, MackayAM, BeckSC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–7.
34. KopenGC, ProckopDJ, PhinneyDG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 1999; 96: 10711–16.
35. LiuYP, SeckinH, IzciY, et al. Neuroprotective effects of mesenchymal stem cells derived from human embryonic stem cells in transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 2009; 29: 780–91.
36. UccelliA, MorettaL, PistoiaV. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8: 726–36.
37. PayneN, SiatskasC, BernardCC. The promise of stem cell and regenerative therapies for multiple sclerosis. J Autoimmun 2008; 31: 288–94.
38. UccelliA, ZappiaE, BenvenutoF, et al. Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection. Expert Opin Biol Ther 2006; 6: 17–22.
39. AggarwalS, PittengerMF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815–22.
40. NemethK, LeelahavanichkulA, YuenPS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15: 42–9.
41. BaiL, LennonDP, EatonV, et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009; 57: 1192–203.
42. BartholomewA, SturgeonC, SiatskasM, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42–8.
43. MaoF, XuWR, QianH, et al. Immunosuppressive effects of mesenchymal stem cells in collagen-induced mouse arthritis. Inflamm Res 2010; 59: 219–25.
44. SchenaF, GambiniC, GregorioA, et al. Interferon-gamma-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Arthritis Rheum 2010; 62: 2776–86.
45. ZappiaE, CasazzaS, PedemonteE, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005; 106: 1755–61.
46. GordonD, PavlovskaG, UneyJB, et al. Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis. J Neuropathol Exp Neurol 2010; 69: 1087–95.
47. KeirsteadHS, NistorG, BernalG, et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005; 25: 4694–705.
48. RasmussonI, RingdenO, SundbergB, et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003; 76: 1208–13.
49. ZhangJ, LiY, ChenJ, et al. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 2005; 195: 16–26.
50. BaiL, CaplanA, LennonD, et al. Human mesenchymal stem cells signals regulate neural stem cell fate. Neurochem Res 2007; 32: 353–62.
51. ZhangS, JiaZ, GeJ, et al. Purified human bone marrow multipotent mesenchymal stem cells regenerate infarcted myocardium in experimental rats. Cell Transplant 2005; 14: 787–98.
52. RafeiM, CampeauPM, Aguilar-MahechaA, et al. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. J Immunol 2009; 182: 5994–6002.
53. Di NicolaM, Massimo GianniA. Dendritic cells. Suppl Tumori 2002; 1: S29–31.
54. NautaAJ, FibbeWE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110: 3499–506.
55. PhinneyDG, IsakovaI. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des 2005; 11: 1255–65.
56. AlexanianAR. Epigenetic modifiers promote efficient generation of neural-like cells from bone marrow-derived mesenchymal cells grown in neural environment. J Cell Biochem 2007; 100: 362–71.
57. LaflammeMA, MurryCE. Regenerating the heart. Nat Biotechnol 2005; 23: 845–56.
58. ChenJ, LiY, KatakowskiM, et al. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 2003; 73: 778–86.
59. LiY, ChenJ, ZhangCL, et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 2005; 49: 407–17.
60. MurphyJM, FinkDJ, HunzikerEB, et al. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003; 48: 3464–74.
61. UccelliA, MancardiG, ChiesaS. Is there a role for mesenchymal stem cells in autoimmune diseases? Autoimmunity 2008; 41: 592–5.
62. PfeifferSE, WarringtonAE, BansalR. The oligodendrocyte and its many cellular processes. Trends Cell Biol 1993; 3: 191–7.
63. HuillardE, ZiercherL, BlondO, et al. Disruption of CK2beta in embryonic neural stem cells compromises proliferation and oligodendrogenesis in the mouse telencephalon. Mol Cell Biol 2010; 30: 2737–49.
64. ParrasCM, HuntC, SugimoriM, et al. The proneural gene Mash1 specifies an early population of telencephalic oligodendrocytes. J Neurosci 2007; 27: 4233–42.
65. OkuH, SugiyamaT, KojimaS, et al. Experimental optic cup enlargement caused by endothelin-1-induced chronic optic nerve head ischemia. Surv Ophthalmol 1999; 44: S74–84.
66. Alvarez-BuyllaA, LimDA. For the long run: maintaining germinal niches in the adult brain. Neuron 2004; 41: 683–6.
67. ZhangSC, LundbergC, LipsitzD, et al. Generation of oligodendroglial progenitors from neural stem cells. J Neurocytol 1998; 27: 475–89.
68. BrustleO, JonesKN, LearishRD, et al. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 1999; 285: 754–6.
69. GensertJM, GoldmanJE. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 1997; 19: 197–203.
70. EinsteinO, KarussisD, GrigoriadisN, et al. Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis. Mol Cell Neurosci 2003; 24: 1074–82.
71. PluchinoS, ZanottiL, RossiB, et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005; 436: 266–71.
72. CasellaGT, BungeRP, WoodPM. Improved method for harvesting human Schwann cells from mature peripheral nerve and expansion in vitro. Glia 1996; 17: 327–38.
73. LeviAD, BungeRP, LofgrenJA, et al. The influence of heregulins on human Schwann cell proliferation. J Neurosci 1995; 15: 1329–40.
74. RutkowskiJL, KirkCJ, LernerMA, et al. Purification and expansion of human Schwann cells in vitro. Nat Med 1995; 1: 80–3.
75. CaddickJ, KinghamPJ, GardinerNJ, et al. Phenotypic and functional characteristics of mesenchymal stem cells differentiated along a Schwann cell lineage. Glia 2006; 54: 840–9.
76. FernandesKJ, McKenzieIA, MillP, et al. A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 2004; 6: 1082–93.
77. StangelM, HartungHP. Remyelinating strategies for the treatment of multiple sclerosis. Prog Neurobiol 2002; 68: 361–76.
78. BungeMB. Novel combination strategies to repair the injured mammalian spinal cord. J Spinal Cord Med 2008; 31: 262–9.
79. BramlettHM, DietrichWD. Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies. Prog Brain Res 2007; 161: 125–41.
80. EnzmannGU, BentonRL, TalbottJF, et al. Functional considerations of stem cell transplantation therapy for spinal cord repair. J Neurotrauma 2006; 23: 479–95.
81. TengYD, LiaoWL, ChoiH, et al. Physical activity-mediated functional recovery after spinal cord injury: potential roles of neural stem cells. Regen Med 2006; 1: 763–76.
82. CouttsM, KeirsteadHS. Stem cells for the treatment of spinal cord injury. Exp Neurol 2008; 209: 368–77.
83. JohnsonPJ, TataraA, ShiuA, et al. Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant 2010; 19: 89–101.
84. KabatasS, TengYD. Potential roles of the neural stem cell in the restoration of the injured spinal cord: review of the literature. Turk Neurosurg 2010; 20: 103–10.
85. AlilainWJ, HornKP, HuH, et al. Functional regeneration of respiratory pathways after spinal cord injury. Nature 2011; 475: 196–200.
86. JaderstadJ, JaderstadLM, LiJ, et al. Communication via gap junctions underlies early functional and beneficial interactions between grafted neural stem cells and the host. Proc Natl Acad Sci U S A 2010; 107: 5184–9.
87. LuP, JonesLL, SnyderEY, et al. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 2003; 181: 115–29.
88. RedmondDE, BjugstadKB, TengYD, et al. Behavioral improvement in a primate Parkinson’s model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci U S A 2007; 104: 12175–80.
89. TengYD, MocchettiI, Taveira-DaSilvaAM, et al. Basic fibroblast growth factor increases long-term survival of spinal motor neurons and improves respiratory function after experimental spinal cord injury. J Neurosci 1999; 19: 7037–47.
90. ParsonsXH, TengYD, SnyderEY. Important precautions when deriving patient-specific neural elements from pluripotent cells. Cytotherapy 2009; 11: 815–24.
91. SharpJ, FrameJ, SiegenthalerM, et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells 2010; 28: 152–63.
92. GoelS, FujiharaM, TsuchiyaK, et al. Multipotential ability of primitive germ cells from neonatal pig testis cultured in vitro. Reprod Fertil Dev 2009; 21: 696–708.
93. ReierPJ. Cellular transplantation strategies for spinal cord injury and translational neurobiology. NeuroRx 2004; 1: 424–51.
94. ChoppM, ZhangXH, LiY, et al. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 2000; 11: 3001–5.
95. OhtaM, SuzukiY, NodaT, et al. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol 2004; 187: 266–78.
96. de HaroJ, ZuritaM, AyllonL, et al. Detection of 111In-oxine-labeled bone marrow stromal cells after intravenous or intralesional administration in chronic paraplegic rats. Neurosci Lett 2005; 377: 7–11.
97. VaqueroJ, ZuritaM, OyaS, et al. Cell therapy using bone marrow stromal cells in chronic paraplegic rats: systemic or local administration? Neurosci Lett 2006; 398: 129–34.
98. OkanoH, OgawaY, NakamuraM, et al. Transplantation of neural stem cells into the spinal cord after injury. Semin Cell Dev Biol 2003; 14: 191–8.
99. HofstetterCP, SchwarzEJ, HessD, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 2002; 99: 2199–204.
100. SasakiM, HonmouO, AkiyamaY, et al. Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons. Glia 2001; 35: 26–34.
101. AkiyamaY, RadtkeC, KocsisJD. Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci 2002; 22: 6623–30.
102. BakshiA, BarshingerAL, SwangerSA, et al. Lumbar puncture delivery of bone marrow stromal cells in spinal cord contusion: a novel method for minimally invasive cell transplantation. J Neurotrauma 2006; 23: 55–65.
103. YanoS, KurodaS, LeeJB, et al. In vivo fluorescence tracking of bone marrow stromal cells transplanted into a pneumatic injury model of rat spinal cord. J Neurotrauma 2005; 22: 907–18.
104. DormadySP, BashayanO, DoughertyR, et al. Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment. J Hematother Stem Cell Res 2001; 10: 125–40.
105. RojasM, XuJ, WoodsCR, et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005; 33: 145–52.
106. FerrariG, Cusella-De AngelisG, ColettaM, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998; 279: 1528–30.
107. HuDZ, ZhouLF, ZhuJH. Marrow stromal cells administrated intracisternally to rats after traumatic brain injury migrate into the brain and improve neurological function. Chin Med J 2004; 117: 1576–8.
108. ChenQ, LongY, YuanX, et al. Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors. J Neurosci Res 2005; 80: 611–19.
109. ChenX, LiY, WangL, et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 2002; 22: 275–9.
110. MahmoodA, LuD, QuC, et al. Human marrow stromal cell treatment provides long-lasting benefit after traumatic brain injury in rats. Neurosurgery 2005; 57: 1026–31.
111. ChandranS, CompstonA. Neural stem cells as a potential source of oligodendrocytes for myelin repair. J Neurol Sci 2005; 233: 179–81.
112. BambakidisNC, MillerRH. Transplantation of oligodendrocyte precursors and sonic hedgehog results in improved function and white matter sparing in the spinal cords of adult rats after contusion. Spine J 2004; 4: 16–26.
113. SiebertJR, StelznerDJ, OsterhoutDJ. Chondroitinase treatment following spinal contusion injury increases migration of oligodendrocyte progenitor cells. Exp Neurol 2011; 231: 19–29.
114. LeporeAC, BakshiA, SwangerSA, et al. Neural precursor cells can be delivered into the injured cervical spinal cord by intrathecal injection at the lumbar cord. Brain Res 2005; 1045: 206–16.
115. CaoQ, HeQ, WangY, et al. Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury. J Neurosci 2010; 30: 2989–3001.
116. KerrCL, LetzenBS, HillCM, et al. Efficient differentiation of human embryonic stem cells into oligodendrocyte progenitors for application in a rat contusion model of spinal cord injury. Int J Neurosci 2010; 120: 305–13.
117. RonaghiM, ErcegS, Moreno-ManzanoV, et al. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? Stem Cells 2010; 28: 93–9.
118. LabombardaF, GonzalezS, LimaA, et al. Progesterone attenuates astro- and microgliosis and enhances oligodendrocyte differentiation following spinal cord injury. Exp Neurol 2011; 231: 135–46.
119. PotterP. Art, science, and life’s enigmas. Emerg Infect Dis 2006; 12: 1308–9.
120. RavenscroftAJ. Chronic pain after spinal cord injury: a survey of practice in spinal injury units in the USA. Spinal Cord 2000; 38: 658–60.
121. KennedyP, RogersBA. Anxiety and depression after spinal cord injury: a longitudinal analysis. Arch Phys Med Rehabil 2000; 81: 932–7.
122. KennedyP, SherlockO, SanduN. Rehabilitation outcomes in people with pre-morbid mental health disorders following spinal cord injury. Spinal Cord 2009; 47: 290–4.
123. NoreauL, FougeyrollasP. Long-term consequences of spinal cord injury on social participation: the occurrence of handicap situations. Disabil Rehabil 2000; 22: 170–80.
124. McDonaldJW, SadowskyC. Spinal-cord injury. Lancet 2002; 359: 417–25.
125. LytleJM, ChittajalluR, WrathallJR, et al. NG2 cell response in the CNP-EGFP mouse after contusive spinal cord injury. Glia 2009; 57: 270–85.
126. KakulasBA, Neuropathology: the foundation for new treatments in spinal cord injury. Spinal Cord 2004; 42: 549–63.
127. ErcegS, RonaghiM, OriaM, et al. Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection. Stem Cells 2010; 28: 1541–9.
128. FeiginI, OgataJ. Schwann cells and peripheral myelin within human central nervous tissues: the mesenchymal character of Schwann cells. J Neuropathol Exp Neurol 1971; 30: 603–12.
129. BlackJA, WaxmanSG, SmithKJ. Remyelination of dorsal column axons by endogenous Schwann cells restores the normal pattern of Nav1.6 and Kv1.2 at nodes of Ranvier. Brain 2006; 129: 1319–29.
130. DavidS, AguayoAJ. Axonal elongation into peripheral nervous system “bridges” after central nervous system injury in adult rats. Science 1981; 214: 931–3.
131. BachelinC, LachapelleF, GirardC, et al. Efficient myelin repair in the macaque spinal cord by autologous grafts of Schwann cells. Brain 2005; 128: 540–9.
132. XuXM, ChenA, GuenardV, et al. Bridging Schwann cell transplants promote axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord. J Neurocytol 1997; 26: 1–16.
133. XuXM, GuenardV, KleitmanN, et al. Axonal regeneration into Schwann cell-seeded guidance channels grafted into transected adult rat spinal cord. J Comp Neurol 1995; 351: 145–60.
134. BanDX, NingGZ, FengSQ, et al. Combination of activated Schwann cells with bone mesenchymal stem cells: the best cell strategy for repair after spinal cord injury in rats. Regen Med 2011; 6: 707–20.
135. KalbR. The protean actions of neurotrophins and their receptors on the life and death of neurons. Trends Neurosci 2005; 28: 5–11.
136. XuXM, GuenardV, KleitmanN, et al. A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp Neurol 1995; 134: 261–72.
137. OudegaM, XuXM, GuenardV, et al. A combination of insulin-like growth factor-I and platelet-derived growth factor enhances myelination but diminishes axonal regeneration into Schwann cell grafts in the adult rat spinal cord. Glia 1997; 19: 247–58.
138. HawthorneAL, HuH, KunduB, et al. The unusual response of serotonergic neurons after CNS Injury: lack of axonal dieback and enhanced sprouting within the inhibitory environment of the glial scar. J Neurosci 2011; 31: 5605–16.
139. HakimEA, BakheitAM. A study of the factors which influence the length of hospital stay of stroke patients. Clin Rehabil 1998; 12: 151–6.
140. RafalowskaJ. Experimental and human ischaemia: is the penumbra present in human ischaemic stroke? Folia Neuropathol 2002; 40: 211–17.
141. TouzaniO, YoungAR, DerlonJM, et al. Sequential studies of severely hypometabolic tissue volumes after permanent middle cerebral artery occlusion. A positron emission tomographic investigation in anesthetized baboons. Stroke 1995; 26: 2112–19.
142. GrabowskiM, JohanssonBB, BrundinP. Survival of fetal neocortical grafts implanted in brain infarcts of adult rats: the influence of postlesion time and age of donor tissue. Exp Neurol 1994; 127: 126–36.
143. MattssonB, SorensenJC, ZimmerJ, et al. Neural grafting to experimental neocortical infarcts improves behavioral outcome and reduces thalamic atrophy in rats housed in enriched but not in standard environments. Stroke 1997; 28: 1225–31; 1231–2 (discussion).
144. WarachS, MosleyM, SorensenAG, et al. Time course of diffusion imaging abnormalities in human stroke. Stroke 1996; 27: 1254–6.
145. SasakiJ, IshikawaK, KobayashiK, et al. Neuronal expression of the fukutin gene. Hum Mol Genet 2000; 9: 3083–90.
146. DarsaliaV, HeldmannU, LindvallO, et al. Stroke-induced neurogenesis in aged brain. Stroke 2005; 36: 1790–5.
147. JinK, WangX, XieL, et al. Evidence for stroke-induced neurogenesis in the human brain. Proc Natl Acad Sci U S A 2006; 103: 13198–202.
148. MacasJ, NernC, PlateKH, et al. Increased generation of neuronal progenitors after ischemic injury in the aged adult human forebrain. J Neurosci 2006; 26: 13114–19.
149. Marti-FabregasJ, Romaguera-RosM, Gomez-PinedoU, et al. Proliferation in the human ipsilateral subventricular zone after ischemic stroke. Neurology 2010; 74: 357–65.
150. MingerSL, EkonomouA, CartaEM, et al. Endogenous neurogenesis in the human brain following cerebral infarction. Regen Med 2007; 2: 69–74.
151. JinK, WangX, XieL, et al. Transgenic ablation of doublecortin-expressing cells suppresses adult neurogenesis and worsens stroke outcome in mice. Proc Natl Acad Sci U S A 2010; 107: 7993–8.
152. TaniJ, UmbasR. Recent progressions in stem cell research: breakthroughs achieved and challenges faced. Acta Med Indones 2009; 41: 30–5.
153. ChenJ, LiY, WangL, et al. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci 2001; 189: 49–57.
154. LiY, ChoppM. Marrow stromal cell transplantation in stroke and traumatic brain injury. Neurosci Lett 2009; 456: 120–3.
155. OndaT, HonmouO, HaradaK, et al. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab 2008; 28: 329–40.
156. BaoX, WeiJ, FengM, et al. Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res 2011; 1367: 103–13.
157. WakabayashiK, NagaiA, SheikhAM, et al. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J Neurosci Res 2010; 88: 1017–25.
158. JiangY, JahagirdarBN, ReinhardtRL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41–9.
159. DarA, KollettO, LapidotT. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol 2006; 34: 967–75.
160. KuciaM, Zuba-SurmaE, WysoczynskiM, et al. Physiological and pathological consequences of identification of very small embryonic like (VSEL) stem cells in adult bone marrow. J Physiol Pharmacol 2006; 57: 5–18.
161. TangYL, HuangJF, CaiSH, et al. Nitrogen contents of rice panicle and paddy by hyperspectral remote sensing. Pak J Biol Sci 2007; 10: 4420–5.
162. AllicksonJG, SanchezA, YefimenkoN, et al. Recent studies assessing the proliferative capability of a novel adult stem cell identified in menstrual blood. Open Stem Cell J 2011; 3: 4–10.
163. CoyneTM, MarcusAJ, WoodburyD, et al. Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells 2006; 24: 2483–92.
164. ShenLH, LiY, ChenJ, et al. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab 2007; 27: 6–13.
165. YasuharaT, MatsukawaN, HaraK, et al. Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. Stem Cells Dev 2009; 18: 1501–14.
166. MandaiK, MatsumotoM, KitagawaK, et al. Ischemic damage and subsequent proliferation of oligodendrocytes in focal cerebral ischemia. Neuroscience 1997; 77: 849–61.
167. GregersenR, ChristensenT, LehrmannE, et al. Focal cerebral ischemia induces increased myelin basic protein and growth-associated protein-43 gene transcription in peri-infarct areas in the rat brain. Exp Brain Res 2001; 138: 384–92.
168. TanakaK, NogawaS, SuzukiS, et al. Upregulation of oligodendrocyte progenitor cells associated with restoration of mature oligodendrocytes and myelination in peri-infarct area in the rat brain. Brain Res 2003; 989: 172–9.
169. KuhnHG, WinklerJ, KempermannG, et al. Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci 1997; 17: 5820–9.
170. FallonJ, ReidS, KinyamuR, et al. In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain. Proc Natl Acad Sci U S A 2000; 97: 14686–91.
171. KomitovaM, PerfilievaE, MattssonB, et al. Enriched environment after focal cortical ischemia enhances the generation of astroglia and NG2 positive polydendrocytes in adult rat neocortex. Exp Neurol 2006; 199: 113–21.